Profile
Mr. Michael Graves is a Chairman & Chief Executive Officer at Eagle Pharmaceuticals, Inc. and an Executive Chairman at Nanocopoeia, Inc. He is on the Board of Directors at RiboCor, Inc. Mr. Graves was previously employed as a President & Chief Executive Officer by Paddock Laboratories, Inc., a President-Generic Products Division by Par Pharmaceutical Cos., Inc., and a President-Generic Products Division by Par Pharmaceutical, Inc. He received his undergraduate degree from State University of New York at Buffalo.
Michael Graves active positions
| Companies | Position | Start |
|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Chief Executive Officer | 27/11/2023 |
Ribocor, Inc.
Ribocor, Inc. Pharmaceuticals: MajorHealth Technology Developes nutritional, medical and pharmaceutical products | Director/Board Member | 01/01/2012 |
Former positions of Michael Graves
| Companies | Position | End |
|---|---|---|
Paddock Laboratories, Inc.
Paddock Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bioequivalent generic pharmaceuticals | Chief Executive Officer | 01/07/2011 |
| PAR PHARMACEUTICAL COMPANIES, INC. | Corporate Officer/Principal | 15/11/2006 |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Corporate Officer/Principal | 01/01/2006 |
Nanocopoeia, Inc.
Nanocopoeia, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical formulation, medical device coating and specialty biotechnology research | Chairman | - |
Training of Michael Graves
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Endo Generics Holdings, Inc.
Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States | Health Technology |
Eagle Pharmaceuticals, Inc.
Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Health Technology |
Paddock Laboratories, Inc.
Paddock Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bioequivalent generic pharmaceuticals | Health Technology |
Ribocor, Inc.
Ribocor, Inc. Pharmaceuticals: MajorHealth Technology Developes nutritional, medical and pharmaceutical products | Health Technology |
Nanocopoeia, Inc.
Nanocopoeia, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical formulation, medical device coating and specialty biotechnology research | Commercial Services |
- Stock Market
- Insiders
- Michael Graves
















